1. Small extracellular vesicle‐based human melanocyte and melanoma signature.
- Author
-
Agüera‐Lorente, Andrea, Alonso‐Pardavila, Ainhoa, Larrinaga, María, Boyano, María Dolores, González, Esperanza, Falcón‐Pérez, Juan Manuel, Asumendi, Aintzane, and Apraiz, Aintzane
- Subjects
EPITHELIAL-mesenchymal transition ,EXTRACELLULAR vesicles ,TENASCIN ,MELANOMA ,PHENOL oxidase - Abstract
Intercellular communication is a cell‐type and stimulus‐dependent event driven not only by soluble factors but also by extracellular vesicles (EVs). EVs include vesicles of different size and origin that contain a myriad of molecules. Among them, small EVs (sEV; <200 nm) have been shown to modulate not just regional cell responses but also distant organ behavior. In cancer, distant organ modulation by sEVs has been associated to disease dissemination, which is one of the main concerns in melanoma. Description of broadly conserved alterations in sEV‐contained molecules represents a strategy to identify key modifications in cellular communication as well as new disease biomarkers. Here, we characterize proteomes of cutaneous melanocyte and melanoma‐derived sEVs to deepen on the landscape of normal and disease‐related cell communication. Results reveal the presence of unique protein signatures for melanocytes and melanoma cells that reflect cellular transformation‐related profound modifications. Melanocyte‐derived sEVs are enriched in oxidative metabolism (e.g., aconitase 2, ACO2) or pigmentation (e.g., tyrosinase, TYR) related proteins while melanoma‐derived sEVs reflect a generalized decrease in mature melanocytic markers (e.g., melanoma antigen recognized by T‐cells 1, MART‐1, also known as MLANA) and an increase in epithelial to mesenchymal transition (EMT)‐related adhesion molecules such as tenascin C (TNC). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF